XFOR
XFOR
NASDAQ · Biotechnology

X4 Pharmaceuticals Inc

$3.44
+0.09 (+2.69%)
As of Nov 7, 2:12 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +726.2% upside
Low Target $21.41
Average Target $28.42
High Target $38.37
Current Price $3.44
Current
$3.44
Target
$28.42
$21.41 $28.42 avg $38.37
Scenario Analysis
Bear Case
$21.41
522.4%
Low target
Base Case
$28.42
+726.2%
Avg target
Bull Case
$38.37
+1,015.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.83
-28.8% from high
52-Week Low
$2.43
+41.6% from low
Target vs 52W High
$28.42
+488.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%